Monday, July 27, 2020

Financial Press Release: 4 - Revance Therapeutics, Inc. (0001479290) (Issuer)

Filed: 2020-07-27 AccNo: 0001479290-20-000082 Size: 13 KB

Filed July 27, 2020 at 06:57PM
Read more on SEC.gov
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)